MedMira Grants Stock Options to Employees and Directors
14 October 2011 - 12:23AM
PR Newswire (Canada)
HALIFAX, Oct. 14, 2011 /CNW/ - MedMira Inc., ("MedMira") , a
developer and marketer of rapid diagnostic technology and
solutions, today announced that the Board of Directors granted a
total of 3,290,000 options to purchase commons shares to its
employees under the Stock Option Plan approved at the Company's AGM
held on January 27, 2011. Of this total, 2,100,000 options were
issued to Officers and Directors. The options are at an exercise
prices of $0.10 per share and are exercisable for a period of three
years. About MedMira MedMira is a leading developer and
manufacturer of flow-through rapid diagnostics and technologies.
The Company's tests provide hospitals, labs, clinics and
individuals with reliable, rapid diagnosis of infectious diseases.
MedMira diagnostics are sold under the Reveal®, MiraWell®,
Multiplo™, and Miriad brands in global markets. MedMira's rapid HIV
test is the only rapid HIV test in the world to achieve regulatory
approvals in Canada, the United States, China and the European
Union. MedMira's corporate offices and manufacturing facilities are
located in Halifax, Nova Scotia, Canada. For more information visit
MedMira's website at www.medmira.com. This news release contains
forward-looking statements, including statements regarding
development of sales opportunities, which involve risk and
uncertainties and reflect the company's current expectation
regarding future events. Actual events could materially
differ from those projected herein and depend on a number of
factors including, but not limited to, changing market conditions,
successful and timely completion of clinical studies, uncertainties
related to the regulatory approval process, establishment of
corporate alliances and other risks detailed from time to time in
the company quarterly filings. The TSX Venture Exchange has not
reviewed and does not accept responsibility for the adequacy or
accuracy of this statement. MEDMIRA INC. CONTACT: MedMira
Contact:Andrea YoungT. 902-450-1588E. ayoung@medmira.com
Copyright
MedMira (TSXV:MIR)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedMira (TSXV:MIR)
Historical Stock Chart
From Jul 2023 to Jul 2024